Lack of Substantial Neuroendocrine Changes in Short-Term High Dose Cadmium treated Rats
A 35-day cadmium (Cd) 5 mg/kg/day treatment, by oral gavage did not modify adrenal cortex, Leydig cells, thyroid function or autacoid 5-hydroxytryptamine peripheral metabolism but it increased urinary catecholamine excretion and decreased hypothalamic 5-hydroxytryptamine levels. Remarkable Cd concentrations were found at the renal and adrenal level, thymus and spleen on a decreasing scale. Cd brain and testicular concentrations did not change, neither were their histological features appreciable modified. Renal tissue showed marked degenerative changes. The increase in catecholamine excretion may indicate an activation of chromaffin tissue and peripheral adrenergic neurotransmission. Hypothalamic 5-hydroxytryptamine changes focus attention on possible subtle changes of neurotransmitters of the median eminence area, involved in the pituitary control, with a blood-brain barrier more permeable than other areas of the brain.
Key wordsCadmium Neuroendocrine effects Adrenal cortex Brain Serotonin Catecholamines
- Anania V., Desole S., Esposito G., Sama Randaccio F., Miele E. (1983) Levels of monoamines in different regions of the rat brain in heavy metal toxicosis. Presented at the 24th Congress of the European Society of Toxicology, Arch. Toxicol. Suppl. 7, in press.Google Scholar
- Arvidson B. (1981) Is cadmium toxic to the nervous system? Trends in neurol. Sci. 4, pp XI-XIV.Google Scholar
- Givener M.L., Rochefort J.G. (1965) An improved assay of corticosterone in rat serum and adrenal tissue. Steroids 6, 45–49.Google Scholar
- FAO-OMS Commité mixte d’experts des additives alimentaires XVI Rapport Genève avril 4–12 1972.Google Scholar
- Lauwerys R. (1979) Cadmium in man. In: Webb M. (ed.) The chemistry, biochemistry and biology of cadmium, Elsevier North Holland Biomedical press, Amsterdam, pp. 433–455.Google Scholar